Abivax SA American Shares Statistics
Share Statistics
Abivax SA American Shares has 66.20M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 66.20M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 3.89K |
| FTD / Avg. Volume | 3.08% |
Short Selling Information
The latest short interest is 191.90K, so 0.3% of the outstanding shares have been sold short.
| Short Interest | 191.90K |
| Short % of Shares Out | 0.3% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 1.14 |
Valuation Ratios
The PE ratio is -2.86 and the forward PE ratio is -3.42.
| PE Ratio | -2.86 |
| Forward PE | -3.42 |
| PS Ratio | 91.52 |
| Forward PS | 72.4 |
| PB Ratio | 2.16 |
| P/FCF Ratio | -4.34 |
| PEG Ratio | n/a |
Enterprise Valuation
Abivax SA American Shares has an Enterprise Value (EV) of 220.41M.
| EV / Earnings | -1.49 |
| EV / Sales | 47.7 |
| EV / EBITDA | -1.65 |
| EV / EBIT | -1.73 |
| EV / FCF | -2.2 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.28.
| Current Ratio | 4.08 |
| Quick Ratio | 4.08 |
| Debt / Equity | 0.28 |
| Total Debt / Capitalization | 21.89 |
| Cash Flow / Debt | -1.77 |
| Interest Coverage | -9.21 |
Financial Efficiency
Return on equity (ROE) is -0.75% and return on capital (ROIC) is -49.16%.
| Return on Equity (ROE) | -0.75% |
| Return on Assets (ROA) | -0.45% |
| Return on Capital (ROIC) | -49.16% |
| Revenue Per Employee | 74.53K |
| Profits Per Employee | -2.38M |
| Employee Count | 62 |
| Asset Turnover | 0.01 |
| Inventory Turnover | -128.13 |
Taxes
| Income Tax | -4.49M |
| Effective Tax Rate | 0.03 |
Stock Price Statistics
The stock price has increased by -31.9% in the last 52 weeks. The beta is 1.42, so Abivax SA American Shares's price volatility has been higher than the market average.
| Beta | 1.42 |
| 52-Week Price Change | -31.9% |
| 50-Day Moving Average | 9.49 |
| 200-Day Moving Average | 12.3 |
| Relative Strength Index (RSI) | 26.58 |
| Average Volume (20 Days) | 126.10K |
Income Statement
In the last 12 months, Abivax SA American Shares had revenue of $4.62M and earned -$147.74M in profits. Earnings per share was $-3.43.
| Revenue | 4.62M |
| Gross Profit | 3.91M |
| Operating Income | -127.38M |
| Net Income | -147.74M |
| EBITDA | -133.21M |
| EBIT | -127.38M |
| Earnings Per Share (EPS) | -3.43 |
Balance Sheet
The company has $251.94M in cash and $55.46M in debt, giving a net cash position of $196.48M.
| Cash & Cash Equivalents | 251.94M |
| Total Debt | 55.46M |
| Net Cash | 196.48M |
| Retained Earnings | -282.95M |
| Total Assets | 327.06M |
| Working Capital | 215.93M |
Cash Flow
In the last 12 months, operating cash flow was -$100.01M and capital expenditures -$265.00K, giving a free cash flow of -$100.28M.
| Operating Cash Flow | -100.01M |
| Capital Expenditures | -265.00K |
| Free Cash Flow | -100.28M |
| FCF Per Share | -2.26 |
Margins
Gross margin is 97.23%, with operating and profit margins of -2.76K% and -3.20K%.
| Gross Margin | 97.23% |
| Operating Margin | -2.76K% |
| Pretax Margin | -3.29K% |
| Profit Margin | -3.20K% |
| EBITDA Margin | -2.88K% |
| EBIT Margin | -2.76K% |
| FCF Margin | -2.17K% |
Dividends & Yields
ABVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -47.97% |
| FCF Yield | -21.19% |
Analyst Forecast
The average price target for ABVX is $43, which is 501.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $43 |
| Price Target Difference | 501.4% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Scores
| Altman Z-Score | -0.05 |
| Piotroski F-Score | 2 |